How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

546 results for

stroke rehabilitation

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Patient self-testing and self-management of oral anti-coagulants with vitamin K antagonists

with AF or venous thromboembolism (VTE) these new drugs are viable alternatives to warfarin (Connolly et al , ; Schulman et al , , ; Bauersachs et al , ; Granger et al , ; Buller et al , ; Agnelli et al , , ; Giugliano et al , ; Hokusai‐Investigators, ), and these drugs have received National Institute for Health and Care Excellence (NICE) approval for stroke prevention in AF and for the treatment and secondary prevention of VTE. They are not suitable for patients with mechanical heart valves (...) they are not available at present and some patients may prefer warfarin until they are. Finally there will be those patients who prefer a drug that has been around for decades, given that long‐term adverse events for new drugs, albeit unlikely, cannot be known. Cost‐effectiveness of PSM/PST compared to use of NOACs? Although the annual cost of the NOACs is greater than the annual cost of warfarin (including usual UK monitoring costs), when NICE approved dabigatran, rivaroxaban and apixaban for stroke prevention

Full Text available with Trip Pro

2014 British Committee for Standards in Haematology

82. Acute Low Back Pain

Acute Low Back Pain 1 Quality Department Guidelines for Clinical Care Ambulatory Low Back Pain Guideline Team Team leader Anthony E. Chiodo, MD Physical Medicine & Rehabilitation Team members David J. Alvarez, DO Family Medicine Gregory P. Graziano, MD Orthopedic Surgery Andrew J. Haig, MD Physical Medicine & Rehabilitation R. Van Harrison, PhD Medical Education Paul Park, MD Neurosurgery Connie J. Standiford, MD General Internal Medicine Consultant Ronald A. Wasserman, MD Anesthesiology, Back (...) activity. • If pain worse: Consider changing/adding medications, increasing restrictions. • Physical therapy. If no improvement, at 1-2 weeks [IIA*] consider manual physical therapy (spinal manipulation). If at Risk: Chronic Disability Prevention (Table 2) • Patient education [IA*] • Minimize restrictions • Recommend aerobic activities such as walking, biking, swimming and core strengthening exercises (Appendix C) to rehabilitate and prevent recurrent low back pain. • At 2 weeks: If work disability

2011 University of Michigan Health System

83. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

, asymptomatic patients, cardiac magnetic resonance (CMR), cardiac rehabilitation, chest pain, chronic angina, chronic coronary occlusions, chronic ischemic heart disease (IHD), chronic total occlusion, connective tissue disease, coronary artery bypass graft (CABG) versus medical therapy, coronary artery disease (CAD) and exercise, coronary calcium scanning, cardiac/coronary computed tomography angiography (CCTA), CMR angiography, CMR imaging, coronary stenosis, death, depression, detection of CAD (...) Percutaneous Coronary Intervention ( ) ACCF/AHA/SCAI 2011 Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease ( ) AHA/ACCF 2011 UA/NSTEMI: 2007 and 2012 Updates ( , ) ACCF/AHA 2012 Statements NCEP ATP III Implications of Recent Clinical Trials ( , ) NHLBI 2004 National Hypertension Education Program (JNC VII) ( ) NHLBI 2004 Referral, Enrollment, and Delivery of Cardiac Rehabilitation/Secondary Prevention Programs at Clinical Centers

2011 American Heart Association

84. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism

in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89) © NICE 2019. All rights reserved. Subject to Notice of rights ( conditions#notice-of-rights). Page 2 of 41Contents Contents Overview 5 Who is it for? 5 Recommendations 6 1.1 Risk assessment 6 1.2 Giving information and planning for discharge 8 1.3 All patients 10 1.4 Interventions for people with acute coronary syndromes or acute stroke or for acutely ill patients 12 (...) VTE prophylaxis. [2018] [2018] P People using anticoagulation ther eople using anticoagulation therap apy y 1.3.17 Consider VTE prophylaxis for people at increased risk of VTE who are interrupting anticoagulant therapy. [2018] [2018] 1.4 Interventions for people with acute coronary syndromes or acute stroke or for acutely ill patients Acute coronary syndromes Acute coronary syndromes 1.4.1 Be aware that people receiving anticoagulant drugs as part of their treatment for an acute coronary syndrome

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

85. Management of Hip Fractures in the Elderly

and Harms of Implementing this Recommendation 195 Future Research 195 Unstable Intertrochanteric Fractures 196 Rationale 196 Risks and Harms of Implementing this Recommendation 196 12 Future Research 196 Results 198 VTE Prophylaxis 219 Rationale 219 Risks and Harms of Implementing this Recommendation 219 Future Research 219 Results 220 Transfusion Threshold 254 Rationale 254 Risks and Harms of Implementing this Recommendation 254 Future Research 254 Results 255 Rehabilitation 258 Sub-Recommendation

2014 American Academy of Orthopaedic Surgeons

86. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy

paroxysmal or chronic, also associated with various degrees of heart failure and an increased risk of systemic thromboembolism and both fatal and nonfatal stroke. Figure 2. Prognosis profiles for HCM and targets for therapy. AF indicates atrial fibrillation. Modified with permission from Maron et al. The natural history of HCM can be altered by a number of therapeutic interventions: ICDs for secondary or primary prevention of sudden death in patients with risk factors ; drugs appropriate to control heart

2011 American Heart Association

87. Percutaneous Coronary Intervention: Guideline For

After DES e88 6.4. Clinical Follow-Up e88 6.4.1. Exercise Testing: Recommendations e88 6.4.2. Activity and Return to Work e89 6.4.3. Cardiac Rehabilitation: Recommendation e89 6.5. Secondary Prevention e89 7. Quality and Performance Considerations e90 7.1. Quality and Performance: Recommendations e90 7.2. Training e90 7.3. Certi?cation and Maintenance of Certi?cation: Recommendation e90 7.4. Operator and Institutional Competency and Volume: Recommendations e90 7.5. Participation in ACC NCDR (...) stents (BMS), cardiac rehabilitation, chronic stable angina, complication, coronary bifurcation lesion, coronary calci?ed lesion, coronary chronic total occlusion (CTO), coronary ostial lesions, coronary stent (BMS and drug-eluting stents e48 Levine et al. JACC Vol. 58, No. 24, 2011 2011 ACCF/AHA/SCAI PCI Guideline December 6, 2011:e44–122[DES]; and BMS versus DES), diabetes, distal embolization, distal protection, elderly, ethics, late stent thrombosis, medical therapy, microembolization, mortality

2011 American College of Cardiology

88. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery

Patients .e683 4.9. Cardiac Rehabilitation: Recommendation .e683 4.10. Perioperative Monitoring .e684 Hillis et al 2011 ACCF/AHA CABG Guideline e653 Downloaded from by on March 27, 20194.10.1. Electrocardiographic Monitoring: Recommendations .e684 4.10.2. Pulmonary Artery Catheterization: Recommendations .e684 4.10.3. Central Nervous System Monitoring: Recommendations .e684 5. CABG-Associated Morbidity and Mortality: Occurrence and Prevention .e685 5.1. Public Reporting (...) of Cardiac Surgery Outcomes: Recommendation .e685 5.1.1. Use of Outcomes or Volume as CABG Quality Measures: Recommendations .e686 5.2. Adverse Events .e687 5.2.1. Adverse Cerebral Outcomes .e687 Stroke .e687 Use of Epiaortic Ultra- sound Imaging to Reduce Stroke Rates: Recom- mendation .e687 The Role of Preoperative Carotid Artery Noninva- sive Screening in CABG Patients: Recommenda- tions .e687 Delirium .e689 Postoperative Cognitive Impairment .e689

2011 American Heart Association

89. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

angioplasty , randomized controlled trial (RCT) , percutaneous coronary intervention (PCI) and angina , angina reduction , antiplatelet therapy , bare-metal stents (BMS) , cardiac rehabilitation , chronic stable angina , complication , coronary bifurcation lesion , coronary calcified lesion , coronary chronic total occlusion (CTO) , coronary ostial lesions , coronary stent (BMS and drug-eluting stents [DES]; and BMS versus DES) , diabetes , distal embolization , distal protection , elderly , ethics , late (...) -intermediate SYNTAX score of <33, bifurcation left main CAD); and 2) clinical characteristics that predict an increased risk of adverse surgical outcomes (eg, moderate-severe chronic obstructive pulmonary disease, disability from previous stroke, or previous cardiac surgery; STS-predicted risk of operative mortality >2%). , , , , , (Level of Evidence: B) Class III: HARM PCI to improve survival should not be performed in stable patients with significant (≥50% diameter stenosis) unprotected left main CAD who

2011 American Heart Association

90. Coronary Artery Bypass Graft Surgery: Guideline For

Rehabilitation: Recommendation e155 4.10. Perioperative Monitoring e156 4.10.1. Electrocardiographic Monitoring: Recommendations e156 4.10.2. Pulmonary Artery Catheterization: Recommendations e156 4.10.3. Central Nervous System Monitoring: Recommendations e156 5. CABG-Associated Morbidity and Mortality: Occurrence and Prevention e157 5.1. Public Reporting of Cardiac Surgery Outcomes: Recommendation e157 5.1.1. Use of Outcomes or Volume as CABG Quality Measures: Recommendations e158 5.2. Adverse Events e159 (...) 5.2.1. Adverse Cerebral Outcomes e159 STROKE e159 USE OF EPIAORTIC ULTRASOUND IMAGING TO REDUCE STROKE RATES: RECOMMENDATION e159 THE ROLE OF PREOPERATIVE CAROTID ARTERY NONINVASIVE SCREENING IN CABG PATIENTS: RECOMMENDATIONS..e160 DELIRIUM e161 POSTOPERATIVE COGNITIVE IMPAIRMENT e161 e124 Hillis et al. JACC Vol. 58, No. 24, 2011 2011 ACCF/AHA CABG Guideline December 6, 2011:e123–2105.2.2. Mediastinitis/Perioperative Infection: Recommendations e161

2011 American College of Cardiology

91. Treatment of cerebellar motor dysfunction and ataxia

inpatient rehabilitation probably improves ataxia and function (1 Class I study); transcranial magnetic stimulation possibly improves cerebellar motor signs at 21 days (1 Class II study). For patients with multiple sclerosis–associated ataxia, the addition of pressure splints possibly has no additional benefit compared with neuromuscular rehabilitation alone (1 Class II study). Data are insufficient to support or refute use of stochastic whole-body vibration therapy (1 Class III study). Glossary AAN (...) direct current stimulation ; TMS = transcranial magnetic stimulation ; TRH = thyrotropin-releasing hormone ; VPA = valproic acid The cerebellum is composed of the vermis, the hemispheres, and 3 cerebellar peduncles on each side, and contributes largely to balance and motor coordination. The causes of cerebellar dysfunction are numerous and include vitamin deficiencies, structural lesions (caused by tumors or trauma), infection, inflammation, toxins, neurodegeneration, genetics, stroke, multiple

2018 American Academy of Neurology

92. Management of stable angina

to prevent new vascular events 17 4.4 Medication concordance 18 5 Interventional cardiology and cardiac surgery 19 5.1 Coronary artery anatomy and definitions 19 5.2 Percutaneous coronary intervention 19 5.3 Coronary artery bypass grafting 21 5.4 Choice of revascularisation technique 23 5.5 Postintervention drug therapy 26 5.6 Postintervention rehabilitation 28 5.7 Managing restenosis 28 5.8 Managing refractory angina 28 6 Stable angina and non-cardiac surgery 30 6.1 Assessment prior to surgery 30 6.2 (...) 2008–2010, as 18% in men and 15% in women aged 65 and over. 5, 6 The presence of stable angina signifies underlying CAD with an associated increased risk of subsequent cardiac events that can be reduced by appropriate medical treatment or surgical intervention. A diagnosis of angina can have a significant impact on the patient's level of functioning. In one survey, patients with angina scored their general health as twice as poor as those who had had a stroke. 7 In another survey, patients had

2018 SIGN

93. Out-of-Hospital Cardiac Arrest Resuscitation Systems of Care: A Scientific Statement From the American Heart Association

of cases occur without any prior recognized heart disease; half occur without any prodromal symptoms. Despite robust systems of care for patients with trauma and rapidly evolving systems of care for patients with ST-segment–elevation myocardial infarction (STEMI) and stroke, the majority of communities do not achieve optimal survival after OHCA because of large discrepancies in resuscitation-related processes of care. As a result, survival to hospital discharge varies significantly both across (...) Association, Inc. Dissemination of Resuscitation Systems of Care Since 2010, many municipalities and regions have continued or begun to implement cardiac resuscitation systems modeled on prior experience implementing and maintaining similar interconnected systems for patients with traumatic injury, STEMI, and acute stroke. To assist in the evolution of regional resuscitation systems of care, several national organized efforts have emerged, including Mission: Lifeline, , Take Heart America

2018 American Heart Association

95. Treatment and recommendations for homeless people with Chronic Non-Malignant Pain

problems, including psychological sequelae of trauma and cognitive impairment. These factors also make adherence to a treatment plan for chronic pain more difficult. Barriers to effective pain management for homeless people include poor understanding of pain management in the general medical community, mutual mistrust between homeless persons and medical providers, lack of access to appropriate pain specialty clinics and other opportunities for rehabilitation, and lack of clear treatment

2011 National Health Care for the Homeless Council

96. Quality Improvement Guidelines for Angiography, Angioplasty, and Stent Placement for the Diagnosis and Treatment of Renal Artery Stenosis in Adults

be associated with a concor- dant increased risk of cardiovascular events, including myocardial infarc- tion and stroke. Thus the benefits of revascularization need to be individu- allydeterminedbasedontheunderly- ingclinicalconditionpromptinginter- vention. Clinical Success Following Renal Revascularization Cure of renovascular hypertension in the patient with atherosclerotic RAS.— Although a distinguishing advantage for revascularizationcomparedwithmedical therapyaloneisthepotentialforahyper- tension cure (...) summary a collabo- rative report from the American Asso- ciationforVascularSurgery/Societyfor VascularSurgery,SocietyforCardiovas- cular Angiography and Interventions, Society for Vascular Medicine and Biol- ogy,SocietyofInterventionalRadiology, andtheACC/AHATaskForceonPrac- tice Guidelines (Writing Committee to DevelopGuidelinesfortheManagement of Patients With Peripheral Arterial Dis- ease) endorsed by the American Associ- ation of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung

2010 Society of Interventional Radiology

97. Diagnosis and Management of Cerebral Venous Thrombosis

Diagnosis and Management of Cerebral Venous Thrombosis Diagnosis and Management of Cerebral Venous Thrombosis | Stroke Search Hello Guest! Login to your account Email Password Keep me logged in Search April 2019 March 2019 February 2019 February 2019 January 2019 Free Access article Share on Jump to Free Access article Diagnosis and Management of Cerebral Venous Thrombosis A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , MD, MSc, FAHA (...) , MD, FAHA, FAAN , MD, MPH, FAHA, FAAN , MD, MHS, FAHA , MD, FAHA , MD, MSc, FAHA , MD , and MD, PhD MD Gustavo Saposnik , Fernando Barinagarrementeria , Robert D. BrownJr , Cheryl D. Bushnell , Brett Cucchiara , Mary Cushman , Gabrielle deVeber , Jose M. Ferro , and Fong Y. Tsai and on behalf of the American Heart Association Stroke Council and the Council on Epidemiology and Prevention Originally published 3 Feb 2011 Stroke. 2011;42:1158–1192 You are viewing the most recent version

2011 Congress of Neurological Surgeons

98. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes

Management) e376 6.2. Medical Regimen and Use of Medications at Discharge: Recommendations e376 6.2.1. Late Hospital and Posthospital Oral Antiplatelet Therapy: Recommendations e376 6.2.2. Combined Oral Anticoagulant Therapy and Antiplatelet Therapy in Patients With NSTE-ACS e378 6.2.3. Platelet Function and Genetic Phenotype Testing e379 6.3. Risk Reduction Strategies for Secondary Prevention e379 6.3.1. Cardiac Rehabilitation and Physical Activity: Recommendation e379 6.3.2. Patient Education (...) , antihypertensives, anti-ischemic therapy, antiplatelet therapy, antithrombotic therapy, beta blockers, biomarkers, calcium channel blockers, cardiac rehabilitation, conservative management, diabetes mellitus, glycoprotein IIb/IIIa inhibitors, heart failure, invasive strategy, lifestyle modification, myocardial infarction, nitrates, non-ST-elevation, P2Y 12 receptor inhibitor, percutaneous coronary intervention, renin-angiotensin-aldosterone inhibitors, secondary prevention, smoking cessation, statins, stent

2014 American Heart Association

99. Tinnitus

Division of Geriatric Medicine and Aging, Columbia University, New Y ork, New Y ork, USA; 11 National Center for Rehabilitative Auditory Research, Portland VA Medical Center, Portland, Oregon, USA; 12 ENT Specialists of Northern Virginia, Falls Church, Virginia, USA; 13 Ochsner Health System, Kenner, Louisiana, USA; 14 Mitchell & Cavallo, P .C., Houston, T exas, USA; 15 Department of Otology and Neurotology, The George Washington University, Washington, DC, USA; 16 Department of Surgery, Cleveland

2014 American Academy of Otolaryngology - Head and Neck Surgery


Guidelines – filter by country